首页|期刊导航|中国药理学与毒理学杂志|M1毒蕈碱型乙酰胆碱受体配体通过G蛋白亚型的差异性偶联调节cAMP蓄积

M1毒蕈碱型乙酰胆碱受体配体通过G蛋白亚型的差异性偶联调节cAMP蓄积OA

M1mAChR ligands modulate cAMP accumulation via differential engagement of G protein subtypes

中文摘要英文摘要

目的 阐明不同M1型毒蕈碱乙酰胆碱受体(M1mAChR)配体对多种G蛋白亚型的偏向性偶联特征,并确定这些特征与细胞内环磷酸腺苷(cAMP)蓄积及钙动员之间的关系.方法 使用瞬时表达人M1mAChR的人胚胎肾293T(HEK293T)细胞,分别给予卡巴胆碱(CCh)、乙酰胆碱(ACh)、毛果芸香碱、iperoxo、McN-A-343、GSK1034702或VU0453595处理(浓度梯度为10-13~10-4 mol·L-1).采用生物发光共振能量转移1(BRET1)和TRUPATH BRET2生物传感器,检测配体诱导的转导蛋白募集以及激活相关的G蛋白重排.利用pGloSensor-22F和Fluo-4 AM分别检测细胞内cAMP蓄积和钙动员.使用NF449、百日咳毒素(PTX)和FR900359分别评估Gαs、PTX敏感的Gαi/o以及Gαq/11的相关贡献.鉴于VU0453595是一种M1正向变构调节剂(PAM),本研究检测了其单独作用;在PAM实验条件下,先用 VU0453595预孵育细胞10 min,随后加入 ACh 10 nmol·L-1.选取代表性配体毛果芸香碱、iperoxo 和 GSK1034702,使用AutoDock Vina与M1mAChR进行分子对接.结果 ACh、CCh和iperoxo在检测的多种传感器中均产生广泛的募集和激活反应.毛果芸香碱对β-抑制蛋白2(β-arrestin2)募集表现出相对偏好,而GSK1034702则保留较强的Gαq/11相关效能,其β-arrestin2效能相对较弱.VU0453595单独用药时未见可靠的激动效应,但在ACh 10 nmol·L-1存在下,VU0453595浓度梯度可引发Gαq/11、Gαs和Gαi1的募集及激活反应.其募集特征相对于Gαs和Gαi1传感器更偏向Gαq/11,而激活相关反应则更具配体依赖性.PTX可逆转毛果芸香碱cAMP反应中的高浓度抑制相,提示PTX敏感的Gαi/o家族信号参与其中.分子对接证实这些配体可稳定结合M1mAChR(结合能为-6.5~-10.2 kcal·mol-1),主要通过氢键与酪氨酸106(Tyr106)和色氨酸378(Trp378)相互作用.结论 M1mAChR配体通过对Gαq、Gαs及Gαi1亚型的差异性偶联与激活,决定了其不同的cAMP积累特征;同时变构调节剂VU0453595对G蛋白偏向性的调控及第二信使激活同样依赖于正构激动剂.

OBJECTIVE To elucidate the biased coupling characteristics of different M1 muscarinic acetylcholine receptor(M1mAChR)ligands to multiple G protein subtypes and to determine how these profiles relate to intracellular cyclic adenosine monophosphate(cAMP)accumulation and calcium mobi-lization.METHODS Human embryonic kidney 293T(HEK293T)cells transiently expressing human M1mAChR were treated with a concentration series(10-13 to 10-4 mol·L-1)of diverse pharmacological ligands,including carbachol(CCh),acetylcholine(ACh),pilocarpine,iperoxo,McN-A-343,GSK1034702,or VU0453595.Bioluminescence resonance energy transfer 1(BRET1)and TRUPATH BRET2 biosen-sors were used to measure ligand-induced transducer recruitment and activation-linked G-protein rear-rangement.Intracellular cAMP accumulation and calcium mobilization were measured using pGloSensor-22F and Fluo-4 AM,respectively.NF449,pertussis toxin(PTX),and FR900359 were used to assess Gαs-,PTX-sensitive Gαi/o-,and Gαq/11-associated contributions.For the positive allosteric modulator(PAM)condition,VU0453595 was preincubated for 10 min before ACh 10 nmol·L-1 was added.Repre-sentative ligands pilocarpine,iperoxo and GSK1034702 were docked to M1mAChR using AutoDock Vina.RESULTS ACh,CCh,and iperoxo produced broad recruitment and activation responses across the measured sensors.Pilocarpine showed a relative preference for β-arrestin2 recruitment,whereas GSK1034702 retained stronger Gαq/11-associated efficacy than β-arrestin2 efficacy.VU0453595 showed no reliable standalone agonist response,but a VU0453595 concentration series in the presence of ACh 10 nmol·L-1 produced responses in Gαq/11,Gαs,and Gαi1 recruitment and activation.The recruitment profile was Gαq/11-oriented relative to the Gαs and Gαi1 sensors,whereas activation-linked responses were more ligand dependent.PTX reversed the high-concentration inhibitory phase of the pilocarpine cAMP response,supporting a contribution from PTX-sensitive Gαi/o-family signaling.Molecular docking confirmed that these ligands stably bound to M1mAChR(-6.5 to-10.2 kcal·mol-1),primarily via hydrogen bonds with tyrosine106 and tryptophan378.CONCLUSION M1mAChR ligands produce distinct cAMP responses through the differential recruitment and activation of Gαq,Gαs,and Gαi1 subtypes.The PAM VU0453595 depends on an orthosteric agonist to modulate G protein bias and second messen-ger signaling.

李广润;林荣泽;边懿泽;汤璐敏;赵兰雪

上海交通大学医学院药理学与化学生物学系,上海 201318上海交通大学医学院,上海 200025上海交通大学医学院药理学与化学生物学系,上海 201318||上海交通大学医学院附属仁济医院肾脏科,上海 200127上海交通大学医学院附属仁济医院浦南分院中医科,上海 200125上海交通大学医学院药理学与化学生物学系,上海 201318||上海交通大学医学院附属仁济医院浦南分院中医科,上海 200125||上海交通大学医学院附属仁济医院肾脏科,上海 200127

医药卫生

M1毒蕈碱型乙酰胆碱受体G蛋白亚型选择性偏向性信号环磷酸腺苷钙正向别构调节剂

M1mAChRG protein subtype selectivitybiased signalingcAMPcalciumpositive allosteric modulator

《中国药理学与毒理学杂志》 2026 (8)

561-575,15

Three-year Action Plan for Shanghai TCM Development and Inheritance Program[ZY(2025-2027)-2-2-1]Key Discipline Construction Program of Shanghai Pudong New Area Health Commission(PWZxk2022-11)Key Discipline Construction Program of Shanghai Pudong New Area Health Commission(PWZxk2025-16)and Shanghai Jiao Tong University Trans-med Awards Research(STAR program)(20230101) 上海市中医药传承创新发展三年行动计划[ZY(2025-2027)-2-2-1]上海市浦东新区卫生健康委员会重点学科建设项目(PWZxk2022-11)上海市浦东新区卫生健康委员会重点学科建设项目(PWZxk2025-16)上海交通大学"交大之星"转化医学研究项目(20230101)

10.3867/j.issn.1000-3002.2026.08943

评论